There’s encouraging news in the battle against blood clots. The global Venous Thromboembolism Treatment Market, valued at USD 1.76 billion in 2024, is expected to reach a substantial USD 2.58 billion by 2034. This signifies a steady growth trajectory at a Compound Annual Growth Rate (CAGR) of 3.9% over the next decade. Venous Thromboembolism, a …
Tag Archives: Venous Thromboembolism Treatment
Global Venous Thromboembolism Treatment Industry on Track for a 3.7% CAGR Surge by 2029 | FMI
The Global Venous Thromboembolism Treatment Industry is likely to grow steadily over the forthcoming years. As indicated by a recent Future Market Insights (FMI) study, the market revenues will observe approximately 3.7% CAGR between 2022 and 2029. More than 3/5th of treatment demand is underpinned by deep venous thrombosis, according to the report. Catheter-directed thrombolysis devices …
Global Venous Thromboembolism Treatment Industry Surpasses US$1.91 Billion with a 3.7% CAGR between 2022 and 2029
The Global Venous Thromboembolism Treatment Industry is set to experience consistent growth in the coming years, according to a recent study conducted by Future Market Insights (FMI). The research indicates that market revenues are expected to demonstrate an approximate Compound Annual Growth Rate (CAGR) of 3.7% between 2022 and 2029. Venous Thromboembolism, a medical condition …
Global Venous Thromboembolism Treatment Industry on a 3.7% CAGR Path through 2029 | FMI Insights
The Global Venous Thromboembolism Treatment Industry is on an upward trajectory, with a projected compound annual growth rate (CAGR) of approximately 3.7% between 2022 and 2029, according to a recent study by Future Market Insights (FMI). The market’s steady rise is underpinned by the strong demand for venous thromboembolism treatment, with deep venous thrombosis accounting …
Powering Progress: Unleashing the Potential of Venous Thromboembolism Treatment Market with a Remarkable 3.7% CAGR by 2029
The global demand for Venous Thromboembolism Treatment Market is likely to grow steadily over the forthcoming years. As indicated by a recent Future Market Insights (FMI) study, the market revenues will observe approximately 3.7% CAGR between 2022 and 2029. More than 3/5th of treatment demand is underpinned by deep venous thrombosis, according to the report. Catheter-directed thrombolysis devices …